Changes of the serum high-sensitivity C-reactive protein and uric acid level in male patients with coronary heart disease and its clinical significance

Yan CUI,Yan LI,Wen DAI
DOI: https://doi.org/10.3969/j.issn.1003-6350.2017.06.018
2017-01-01
Abstract:Objective To investigate the changes of the serum high-sensitivity C-reactive protein (hs-CRP) and uric acid (UA) level in male patients with coronary heart disease (CHD) and its clinical significance. Methods A total of 158 male patients with CHD in Department of Cardiology in our hospital from January 2016 to July 2016 were select-ed. They were divided into three groups:stable angina (SA group, n=55), unstable angina (UA group, n=67), acute myo-cardical infarction (AMI group, n=36). Another 54 subjects who admitted to the hospital due to chest pain and chest pain were enrolled in the same period without CHD were taken as controls (control group). The serum levels of hs-CRP and UA were measured by immune turbidimetry in all patients. The difference of hs-CRP and UA level in CHD patients and control group were statistically analyzed. Results The serum hs-CRP levels of AMI group was (44.86±48.30) mg/mL, which was significantly higher than that in UA group (8.38 ± 13.26) mg/mL, SA group (0.75 ± 0.74) mg/mL and control group (0.79 ± 1.27) mg/mL, and the level UA group was significantly higher than that in SA group and control group, with statistically significant difference (P<0.01). The serum UA levels of UA group was (403.45 ± 95.86) mg/mL, which was significantly higher than that in SA group (343.25±75.09) mg/mL, AMI group (345.66±118.82) mg/mL and control group (339.48 ± 58.28) mg/mL, with statistically significant difference (P<0.01). Conclusion Serum levels of hs-CRP and UA are closely related to the occurrence and development of male CHD, which has clinical value in the diagnosis of male CHD.
What problem does this paper attempt to address?